Literature DB >> 30136416

Care and concern with cannabinoids used therapeutically.

Jennifer H Martin1,2, Noel Cranswick3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30136416      PMCID: PMC6177708          DOI: 10.1111/bcp.13724

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  16 in total

1.  Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects.

Authors:  Laura M Dryburgh; Nanthi S Bolan; Christopher P L Grof; Peter Galettis; Jennifer Schneider; Catherine J Lucas; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2018-08-01       Impact factor: 4.335

2.  Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco, and marijuana.

Authors:  Michael J Rivkin; Peter E Davis; Jennifer L Lemaster; Howard J Cabral; Simon K Warfield; Robert V Mulkern; Caroline D Robson; Ruth Rose-Jacobs; Deborah A Frank
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

Review 3.  Therapeutic use of medicinal cannabis in difficult to manage epilepsy.

Authors:  John A Lawson; Ingrid E Scheffer
Journal:  Br J Clin Pharmacol       Date:  2018-09-05       Impact factor: 4.335

4.  Care and concern with cannabinoids used therapeutically.

Authors:  Jennifer H Martin; Noel Cranswick
Journal:  Br J Clin Pharmacol       Date:  2018-08-22       Impact factor: 4.335

5.  Medicinal cannabis in Australia: the missing links.

Authors:  Jennifer H Martin; Yvonne A Bonomo
Journal:  Med J Aust       Date:  2016-06-06       Impact factor: 7.738

6.  Compassion and evidence in prescribing cannabinoids: a perspective from the Royal Australasian College of Physicians.

Authors:  Jennifer H Martin; Yvonne Bonomo; Adrian Db Reynolds
Journal:  Med J Aust       Date:  2018-02-19       Impact factor: 7.738

7.  Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

Authors:  Orrin Devinsky; J Helen Cross; Linda Laux; Eric Marsh; Ian Miller; Rima Nabbout; Ingrid E Scheffer; Elizabeth A Thiele; Stephen Wright
Journal:  N Engl J Med       Date:  2017-05-25       Impact factor: 91.245

8.  Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).

Authors:  Brian D Klein; Catherine A Jacobson; Cameron S Metcalf; Misty D Smith; Karen S Wilcox; Aidan J Hampson; John H Kehne
Journal:  Neurochem Res       Date:  2017-05-06       Impact factor: 3.996

9.  Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modelling.

Authors:  Zheng Liu; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2018-06-07       Impact factor: 4.335

Review 10.  Cannabis, from plant to pill.

Authors:  Christopher P L Grof
Journal:  Br J Clin Pharmacol       Date:  2018-05-24       Impact factor: 4.335

View more
  4 in total

1.  Cannabinoid use in practice in Australasia-Better guidance and new drug information systems will be essential for prescribers.

Authors:  Jennifer H Martin; Nicholas J Talley
Journal:  Br J Clin Pharmacol       Date:  2019-05-23       Impact factor: 4.335

2.  Care and concern with cannabinoids used therapeutically.

Authors:  Jennifer H Martin; Noel Cranswick
Journal:  Br J Clin Pharmacol       Date:  2018-08-22       Impact factor: 4.335

3.  Clinical trial simulations of the interaction between cannabidiol and clobazam and effect on drop-seizure frequency.

Authors:  Kirsten Riber Bergmann; Karen Broekhuizen; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2019-12-12       Impact factor: 4.335

4.  Parasitic pharmacology: A plausible mechanism of action for cannabidiol.

Authors:  Geert Jan Groeneveld; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2019-07-10       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.